twitter
en POLSKI
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Current issue Archive Videos Articles in press About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
3/2019
vol. 121
 
Share:
Share:
abstract:
Original paper

Choroidal Thickness Changes in Patients with Wet Age-related Macular Degeneration over One Year of Aflibercept Treatment

Izabela Jamiołkowska
1
,
Małgorzata Figurska
1
,
Marek Rękas
1

1.
Ophthalmology Departement, Military Institute of Medicine
Online publish date: 2019/11/18
View full text Get citation
 
PlumX metrics:
Aim
The aim of the study was to analyze choroidal thickness changes in treatment-naive patients with exudative age-related macular degeneration treated with aflibercept in daily clinical practice.

Materials and Methods
Thirty-six patients (36 eyes), aged 78.3±8.7 years, were enrolled in a prospective, non-randomized, one-year study. Aflibercept was administered monthly for three months and then bimonthly in a fixed regimen. Retinal and choroidal thickness were measured manually on optical coherence tomography scans.

Results
Patients gained, on average, 8.5 letters (p<0.001). Central retinal thickness decreased significantly from 337.7±126.5 µm to 272.1±123.1 µm (p<0.05). Subfoveal choroidal thickness decreased significantly after a loading phase: from 190.2 ± 97.7 µm to 177.4 ± 90.0 µm (p<0.05), but the reduction was not significant at 12 months (p=0.078). Choroidal thickness measured nasally from the fovea decreased significantly at each point of follow-up (p<0.05). Subfoveal choroidal thickness decreased significantly from 182.80 ± 91.43 µm to 164.0 ± 86.3 µm (p>0.05) only in patients with visual acuity improvement of > 5 letters on the Early Treatment Diabetic Retinopathy Study chart.

Conclusions
Subfoveal choroidal thickness in patients with neovascular age-related macular degeneration decreased after the loading phase of aflibercept treatment. At 12 months, aflibercept treatment reduced subfoveal choroidal thickness only among patients with visual acuity improvement.

keywords:

exudative age-related macular degeneration, choroid, choroidal thickness, aflibercept

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.